Throughout this document we use numerous acronyms, some of which are not defined as they are presented. See Appendix D for the NCD manual language. Subject: Decision Memorandum on Diagnostic Laboratory Tests using Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced CancerĪfter considering the public comments and additional evidence, we are revising our proposed decision. See Appendix D for the NCD manual language.ĭeputy Director, Coverage and Analysis Groupĭirector, Division of Policy & Evidence Reviewĭeputy Director, Division of Policy & Evidence Review Medicare Administrative Contractors (MACs) may determine coverage of other Next Generation Sequencing (NGS) as a diagnostic laboratory test for patients with cancer only when the test is performed in a CLIA-certified laboratory, ordered by a treating physician and the patient has: results provided to the treating physician for management of the patient using a report template to specify treatment options.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |